446 related articles for article (PubMed ID: 18628474)
1. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
2. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells.
Ferrario D; Collotta A; Carfi M; Bowe G; Vahter M; Hartung T; Gribaldo L
Toxicology; 2009 Jun; 260(1-3):132-41. PubMed ID: 19464579
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
Cao D; Zhao J; Nguyan LN; Nguyen LNT; Khanal S; Dang X; Schank M; Chand Thakuri BK; Wu XY; Morrison ZD; El Gazzar M; Zou Y; Ning S; Wang L; Moorman JP; Yao ZQ
Front Immunol; 2019; 10():1152. PubMed ID: 31191531
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
5. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Cerone MA; Londoño-Vallejo JA; Autexier C
Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163
[TBL] [Abstract][Full Text] [Related]
6. Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro.
Zhang TC; Schmitt MT; Mumford JL
Carcinogenesis; 2003 Nov; 24(11):1811-7. PubMed ID: 12919960
[TBL] [Abstract][Full Text] [Related]
7. Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
Yoon JS; Kim ES; Park BB; Choi JH; Won YW; Kim S; Lee YY
Int J Oncol; 2015 May; 46(5):1953-62. PubMed ID: 25695330
[TBL] [Abstract][Full Text] [Related]
8. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
10. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
13. Ageing and cancer: the telomere and telomerase connection.
Shay JW; Wright WE
Novartis Found Symp; 2001; 235():116-25; discussion 125-9, 146-9. PubMed ID: 11280022
[TBL] [Abstract][Full Text] [Related]
14. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
[TBL] [Abstract][Full Text] [Related]
15. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
16. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
17. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Chan SW; Blackburn EH
Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
Meeker AK
Urol Oncol; 2006; 24(2):122-30. PubMed ID: 16520276
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.
Kim SJ; Kim ES; Kim S; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Int J Oncol; 2017 Dec; 51(6):1739-1746. PubMed ID: 29039521
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
